Departments

Consumers Worldwide Favor Generic Drugs 9/21/2009

Erosion of Branded Dyslipidemia Drug Sales Likely 9/21/2009

FTC Questions Years of Patent Protection for Biotech Drugs 9/21/2009

Greenstone Announces Key Management Appointments 9/21/2009

Deal Finalized Between Sepracor and Teva on Xopenex 5/19/2009

FDA Amends Ban on Unapproved Opioids 5/19/2009

FDA Approves Generic Topamax 5/19/2009

GPhA Applauds Approval of Patent Reform Act 5/19/2009

GPhA Endorses Availability of Biogenerics 5/19/2009

Mylan Files ANDA for Chemo Drug; Sued by Roche 5/19/2009

Mylan Settles With Schering-Plough Over Clarinex 5/19/2009

Prasco to Market and Distribute GSK Generics 5/19/2009

Teva Launches Two New Product 5/19/2009

Dr. Reddy's Launches Five New Generics 3/18/2009

Generics Blamed for Cut in Glaxo Jobs 3/18/2009

Lannett Patents New Manufacturing Method for Morphine Derivatives 3/18/2009

Proposed Bill to Stop Generic Drug Delays 3/18/2009

Teva and Lonza Partner on Biosimilars 3/18/2009

Generic Trends 12/15/2008

GPhA Congratulates President-Elect Obama In congratulating Senator Obama on his election win, Kathleen Jaeger, president and CEO of the Generic Pharmaceutical Association (GPhA), said that Obama and the new Congress "must now tackle the serious challenges facing our economy, including rising health care costs" by increasing access to "affordable generic and biogeneric medicines.

Generic Trends 10/17/2008

FDA Sends Ranbaxy Warning Letters; Import Alert Issued The FDA has sent two Warning Letters to Ranbaxy Laboratories, Ltd.
For more articles, please check our archives.